Inhalation of Nitric oxide Could Treat COVID-19

Researchers at Uppsala University have found that nitric oxide (NO) which was an effective treatment in the 2003 pandemic of SARS is also effective for treating SARS-CoV-2. The SARS-CoV-2 pandemic continues the burden the healthcare systems and economies. Though efforts are put in the development of specific treatments, no prophylactic or effective treatment is currently available. NO is a potent vasodilator with broad-spectrum antimicrobial effect. NO released from S-Nitroso-N-acetylpenicillamine (SNAP) has been proven to decrease the hypoxia in severe acute respiratory syndrome.

The researchers evaluated the in vitro effect of NO for SARS-CoV-2 in Vero E6. SNAP had a dose-dependent inhibitory effect on SARS-CoV-2 replication. Although it did not completely stop the viral replication, it prevented the development of viral cytopathic effects in treated cells. SNAP was also tested on SARS-CoV-3 3CL recombinant protease and a reduction in the protease activity was consistent with S-nitrosation of the enzyme active site cysteine. The researchers also stated that until a vaccine is developed inhalation of NO might be effective for treatment.

To know more about origin, virology of COVID-19, Click here

To know more about emerging themes in COVID-19, Click here

To know more about how WhiteCoats can help you in your professional advancement, visit www.whitecoats.com

Want to set up an online consultation for your practice, Click here

Ref link: https://www.sciencedirect.com/science/article/pii/S2213231720309393

#Featured